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Objectives and Methods
• The aim of this study is to describe the development and 
utilization of analytical tools for rapid, ongoing monitoring of 
drug overdose trends in Kentucky and decedents’ exposure to 
prescribed controlled substances
• Linkage of all-cause death certificate (DC) with prescription drug 
monitoring program (PDMP) records from 2018 to March 2021
• Drug overdose deaths are identified based on underlying cause 
of death (ICD-10 codes: X40-X44, X60-X64, X85, or Y10-Y14)
• Involvement of specific drugs/drug classes in the drug overdose 
death is based on ICD-10 codes (T36-T50) and death certificate 
text analysis
• Drugs listed on DCs are compared with decedents’ past 90 day 
controlled substance prescriptions dispensed
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Results
Drug Overdose Deaths as a Percentage of All-cause Mortality
Kentucky Residents, 2018 Q1 – 2021 Q1
Stratified by Age
Drug overdose death certificates are identified based on underlying cause of death codes in the ICD-10 range X40-X44, X60-X64, X85, or Y10-Y14.
































































Contribution of Specific Drug Classes in Drug Overdose Deaths
Results
Percentage Kentucky Drug Overdose Decedents with Recent Prescriptions for Drugs 
Listed as Contributing Drugs, 2020
Percentage (%) of decedents who received prescriptions for drug 


















*Exact % (cases < 6) need to be suppressed according to the state reporting policy and the data use agreement with the Office of Vital Statics and KASPER.
Conclusions
• A high level of drug overdose deaths was observed in the first months of 
COVID-19 pandemic and sustained at historically high levels during the last 12 
months
• Specifically, increasing involvement of synthetic opioids and 
psychostimulants and decreasing/minimal involvement of heroin in 
drug overdose deaths were observed
• The overwhelming majority of drug overdose decedents did not have recent 
prescription for the controlled substances involved in their drug overdose 
death
• Of 1,462 overdose decedents who died of an overdose involving 
fentanyl, <1% had received a prescription for fentanyl in the previous 
90 days
• The analytical enhancement of KY’s drug overdose surveillance supports 
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